BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5059773)

  • 1. The influence of salicylate on serum TSH concentration in patients with primary hypothyroidism.
    Yamamoto T; Woeber KA; Ingbar SH
    J Clin Endocrinol Metab; 1972 Feb; 34(2):423-6. PubMed ID: 5059773
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioimmunoassay for human thyrotrophin. Clinical value in patients with normal and abnormal thyroid function.
    Mayberry WE; Gharib H; Bilstad JM; Sizemore GW
    Ann Intern Med; 1971 Apr; 74(4):471-80. PubMed ID: 5108040
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioassay and immunoassay measurements of serum thyrotropin in primary hypothyroidism before and after the administration of thyrotropin releasing hormone.
    Miyai K; Azukizawa M; Kumahara Y
    Horm Metab Res; 1974 Jan; 6(1):9-12. PubMed ID: 4206586
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of bioassay and immunoassay measurements of serum thyrotropin (TSH) and study of TSH levels by immunoassay of serum concentrates.
    Adams DD; Kennedy TH; Utiger RD
    J Clin Endocrinol Metab; 1972 Jun; 34(6):1074-9. PubMed ID: 4553516
    [No Abstract]   [Full Text] [Related]  

  • 5. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
    Konno N; Morikawa K
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of thyrotropin (TSH) and prolactin (PRL) release by pyridoxine in chronic primary hypothyroidism.
    Delitala G; Rovasio P; Lotti G
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1019-22. PubMed ID: 925127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analogy of scorbutogenic effects induced by sodium salicylate and gentisate in guinea pig].
    FILOMENI M
    Arch Ital Sci Farmacol; 1952 Jul; 2(3):245-7. PubMed ID: 13008638
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical significance of LATS and TSH in the blood.
    Lemarchand-Béraud T; Griessen M; Scazziga BR
    Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
    [No Abstract]   [Full Text] [Related]  

  • 9. Problems of TSH immunoassay.
    Hall R; Tubmen J; Garry R
    Clin Sci; 1970 Mar; 38(3):18P. PubMed ID: 5442546
    [No Abstract]   [Full Text] [Related]  

  • 10. Large molecular weight TSH-beta: the sole immunoactive form of TSH-beta in certain human sera.
    Kourides IA; Weintraub BD; Maloof F
    J Clin Endocrinol Metab; 1978 Jul; 47(1):24-33. PubMed ID: 95622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile.
    Tagliaferri M; Berselli ME; Calò G; Minocci A; Savia G; Petroni ML; Viberti GC; Liuzzi A
    Obes Res; 2001 Mar; 9(3):196-201. PubMed ID: 11323445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE EFFECTS OF NONCALORIGENIC CONGENERS OF SALICYLATE ON THE PERIPHERAL METABOLISM OF THYROXINE.
    WOEBER KA; INGBAR SH
    J Clin Invest; 1964 May; 43(5):931-42. PubMed ID: 14169522
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the measurement of serum TSH concentration by a supersensitive immunoradiometric assay and conventional radioimmunoassay in various types of hyperthyroidism and hypothyroidism.
    Rajatanavin R; Chailurkit L; Chalayondeja W; Jittivanich U
    J Med Assoc Thai; 1988 Apr; 71(4):203-8. PubMed ID: 3418251
    [No Abstract]   [Full Text] [Related]  

  • 14. [Radioimmunoassay of serum TSH and its utilization in the differential diagnosis of hypothyroidism].
    Bednár J; Nĕmec J; Röhling S
    Cesk Farm; 1975 Jun; 24(4-5):208-11. PubMed ID: 1182824
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum thyrotropin (TSH) levels after thyroid ablation compared with TSH levels after exogenous bovine TSH: implications for 131-I treatment of thyroid carcinoma.
    Hershman JM; Edwards CL
    J Clin Endocrinol Metab; 1972 May; 34(5):814-8. PubMed ID: 5062451
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of thyrotropin (h-TSH) in serums of patients with myxedema of varying etiology treated with thyroid hormones.
    Cotton GE; Gorman CA; Mayberry WE
    N Engl J Med; 1971 Sep; 285(10):529-33. PubMed ID: 5109216
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum HDL-cholesterol in patients with hypothyroidism].
    Shio H
    Horumon To Rinsho; 1983 Mar; 31(3):231-2. PubMed ID: 6872296
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of serum thyrotropin (TSH) by L-dopa in chronic hypothyroidism: interrelationships in the regulation of TSH and prolactin secretion.
    Rapoport B; Refetoff S; Fang VS; Friesen HG
    J Clin Endocrinol Metab; 1973 Feb; 36(2):256-62. PubMed ID: 4630270
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies of the radioimmunochemical determination of human thyroid stimulating hormone (H-TSH)].
    zur Mühlen A von ; Emrich D
    Z Klin Chem Klin Biochem; 1971 May; 9(3):257-65. PubMed ID: 5170452
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of the radioimmunoassay for plasma thyroid-stimulating hormone (TSH) and of the TSH-stimulation test in the diagnosis of 100 consecutive patients with suspected hypothyroidism.
    Irvine WJ; Toft AD; Hunter WM; Kirkham KE
    J Endocrinol; 1973 Jul; 58(1):23-4. PubMed ID: 4722532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.